Yahoo
    Brussels - Delayed Quote EUR

    Gimv NV (GIMB.BR)

    49.45 +0.15 (+0.30%)
    At close: October 30 at 5:35:18 PM GMT+1
    Loading Chart for GIMB.BR
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    3 Financial Stocks Crypto Holders May Prefer to Binance After the Hack

    3 Financial Stocks Crypto Holders May Prefer to Binance After the Hack
    Simply Wall St. 2h ago
    Metsä Board Shares In Focus After Smaller Q3 Loss On Weaker Sales

    Metsä Board Shares In Focus After Smaller Q3 Loss On Weaker Sales
    Simply Wall St. 5h ago
    TAKKT (XTRA:TTK) Stock Sinks As Q3 Earnings Deepen Losses

    TAKKT (XTRA:TTK) Stock Sinks As Q3 Earnings Deepen Losses
    Simply Wall St. 5h ago
    Is Bayer (XTRA:BAYN) Undervalued Following Its Roundup Court Win?

    Is Bayer (XTRA:BAYN) Undervalued Following Its Roundup Court Win?
    Simply Wall St. 6h ago
    How Investors May Respond To TF1 (ENXTPA:TFI) Weaker Earnings Report

    How Investors May Respond To TF1 (ENXTPA:TFI) Weaker Earnings Report
    Simply Wall St. 7h ago
    What Bayer (XTRA:BAYN)'s Roundup Court Win Means For Shareholders

    What Bayer (XTRA:BAYN)'s Roundup Court Win Means For Shareholders
    Simply Wall St. 7h ago
    How 'deeply intertwined' are energy companies in this stage of the AI build-out?

    How 'deeply intertwined' are energy companies in this stage of the AI build-out?
    Yahoo Finance Video 7h ago
    SES and Air Astana Introduce Multi-orbit Inflight Connectivity on A321LR Fleet

    SES and Air Astana Introduce Multi-orbit Inflight Connectivity on A321LR Fleet
    Business Wire 8h ago
    Nextensa NV/SA: Information on the total number of voting rights and shares

    Nextensa NV/SA: Information on the total number of voting rights and shares
    GlobeNewswire 8h ago
    VILNIAUS BALDAI AB condensed interim consolidated financial statements for the twelve months of FY2026 ended August 31, 2026

    VILNIAUS BALDAI AB condensed interim consolidated financial statements for the twelve months of FY2026 ended August 31, 2026
    GlobeNewswire 10h ago
    Next-Generation Adeno-Associated Virus (AAV) Gene Therapy Delivery Market Report 2026 | Capitalize on $11.91B Market as Novartis, Voyager and Affinia Accelerate Engineered Capsids

    Next-Generation Adeno-Associated Virus (AAV) Gene Therapy Delivery Market Report 2026 | Capitalize on $11.91B Market as Novartis, Voyager and Affinia Accelerate Engineered Capsids
    GlobeNewswire 11h ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: